Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06095050 · ClinicalTrials.gov registry record · NA
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
A NA study of Shoulder Pain and Tendinopathy, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT06095050: Recruiting NA study of Shoulder Pain and Tendinopathy, sponsored by Brigham and Women's Hospital.
NCT06095050 is a NA study of Shoulder Pain and Tendinopathy that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 41 participants, below the 100-participant average among 27 other Shoulder Pain trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06095050, a NA study of Shoulder Pain and Tendinopathy, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial in which patients with moderate to severe shoulder pain (Visual Analog Scale (VAS) \> 40), in the setting of rotator cuff tendinopathy refractory to conservative treatment, will be enrolled. The primary aim of the study is to estimate the effect of transcatheter arterial embolization (TAE) with physical therapy (PT) vs PT alone on the change in shoulder pain at 12-month follow up. Scientific objectives also include an assessment of safety of the intervention, assessment of changes in Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity score, Shoulder Pain and Disability Index (SPADI) scores, MRI Tendinopathy Score between the TAE + PT and PT groups.
Primary Outcome
The difference in shoulder visual analog pain scale scores between TAE +PT and PT groups obtained 12 months following intervention vs. pre-intervention. The visual analog scale is ratio scale from 0 to 100 which measures pain symptoms. On this scale higher numbers indicated more severe pain symptoms.
Conditions Studied
Interventions
- OTHER Physical Therapy
- DEVICE Embolization
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2025-01-16 |
| Est. Completion | 2028-04-21 |
| Phase | NA |
What NCT06095050 shows while recruiting
NCT06095050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 100-participant average among 27 other Shoulder Pain trials with a reported enrollment target (59% lower).
The record links to 6 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 2 interventions - of which Physical Therapy is the first listed.
NCT06095050 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06095050 about?
NCT06095050 is a clinical study titled "Embolization Treatment of Chronic Refractory Shoulder Tendinopathy". This is a randomized controlled trial in which patients with moderate to severe shoulder pain (Visual Analog Scale (VAS) \> 40), in the setting of rotator cuff tendinopathy refractory to conservative treatment, will be enrolled. The primary aim of the study is to estimate the effect of transcathete...
What is the current status of trial NCT06095050?
This trial is currently recruiting. It is a NA study. The enrollment target is 41 participants. The study started on 2025-01-16. Estimated completion is 2028-04-21.
What conditions does trial NCT06095050 study?
This clinical trial studies the following conditions: Shoulder Pain, Tendinopathy, Rotator Cuff Tendinitis, Rotator Cuff Tendinosis, Arterial Occlusion.
What interventions are being tested in trial NCT06095050?
The interventions under investigation include: Physical Therapy (OTHER), Embolization (DEVICE).
Who is sponsoring clinical trial NCT06095050?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06095050 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06095050's enrollment target sits among peer trials
41 18th of 27 higher than 10 of 27 other Shoulder Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Outcomes Collection: How Can we do Better?
RECRUITING · NA
-
Zimmer Biomet Shoulder Arthroplasty PMCF
RECRUITING · NA
-
BFRT for Subacromial Pain
RECRUITING · NA
-
Dry Needling and Shoulder Muscle Blood Flow, Motions, and Pain Sensitivity in Individuals with Shoulder Pain
ACTIVE NOT RECRUITING · NA
-
How Dry Needling at the Neck Affects Shoulder Movement, Strength, Pain, and Shoulder Circulation
ACTIVE NOT RECRUITING · NA
-
A Randomized Controlled Trial of Best Approach to Care Compared to Diversified Chiropractic Adjustive Technique
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI